Searching for hematopoietic stem cells: evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow by unknown
Searching for Hematopoietic Stem Cells:  Evidence 
That Thy-l.1 l~ Lin-  Sea-1 + Cells Are the Only Stem 
Cells in C57BL/Ka-Thy-l.1  Bone Marrow 
By Nobuko Uchida and Irving L. Weissman 
From the Howard Hughes Medical Institute, Departments of Pathology and Developmental 
Biology, Stanford University School of Medicine, Stanford, California 94305 
Stlmmal'y 
Hematopoietic stem cells (HSCs) are defined in mice by three activities: they must rescue lethally 
irradiated mice (radioprotection), they must self-renew, and they must restore all blood cell lineages 
permanently. We initially demonstrated that HSCs were contained in a rare ('~0.05%)  subset 
of bone marrow cells with the following surface marker profile: Thy-l.1 l~ Lin-  Sca-l+. These 
cells were capable of long-term, multi-lineage reconstitution and radioprotection of lethally irradiated 
mice with an enrichment that mirrors their representation in bone marrow, namely, 1,000-2,000- 
fold. However, the experiments reported did not exclude the possibility that stem cell activity 
may also  reside in populations  that  are Thy-l.l-,  Sca-l-,  or Lin +.  In this article stem cell 
activity was determined by measuring:  (a) radioprotection provided by sorted cells;  (b) long- 
term,  multi-lineage reconstitution  of these surviving mice;  and (c) long-term,  multi-lineage 
reconstitution by donor cells when radioprotection is provided by coinjection of congenic host 
bone marrow cells. Here we demonstrate that HSC activity was detected in Thy-l.l+, Sca-l+, 
and Lin-  fractions, but not Thy-l.l-,  Sca-l-,  or Lin + bone marrow cells. We conclude that 
Thy-l.1 l~ Lin-  Sca-1  + cells comprise the only adult C57BL/Ka-Thy-l.1  mouse bone marrow 
subset that contains pluripotent  HSCs. 
H 
ematopoietic stem cells (HSCs) 1 are intriguing because 
of their ability to perpetuate themselves (self-renewal) 
and to give rise to progeny that differentiate into all blood 
cell types. Hematopoiesis commences with clonogenic pluripo- 
tent HSCs, which pass through several stages of differentia- 
tion, finally producing functionally mature blood cells (re- 
viewed in reference 1).  Historically,  HSC  have also been 
described as the constituents of bone marrow transplanta- 
tion essential for saving lethally irradiated hosts, presumably 
by self-renewal and long-term, multi-lineage blood cell repopu- 
lations (2-4). 
The concept and definition of HSCs was first developed 
by Till and McCulloch (5). They developed a quantitative 
assay for donogenic bone marrow precursors of myeloerythroid 
cells: namely, the assay for spleen CFU (CFU-S) (5). While 
it was initially believed that CFU-S were equivalent to HSCs, 
it is now accepted that CFU-S are heterogeneous (6-8). The 
CFU-S activity of a cell inoculum can be used as a quantita- 
tive measure of the proliferative and differentiative capacities 
1  Abbreviations  used in this paper: CFU-GM, granulocyte/macrophage  CFU; 
CFU-S, spleen CFU; CFU-T,  thymic CFU; HSC, hematopoietic stem 
cell; Lin, lineage markers; PD, radioprotective  bone marrow cell dose; Rh- 
123, rhodamin~123; Sca-1, stem cell antigen-I; WBM, whole bone marrow. 
of several classes  of hematopoietic progenitors  (8).  Early- 
forming (day 8) CFU-S are derived from more committed 
progenitors, while late-forming (day 12) CFU-S are derived 
from more primitive hematopoietic cells (7). Further, a subset 
of cells, defined as pr~CFU-S, are capable of forming CFU-S 
after secondary bone marrow transplantation (9, 10). How- 
ever, the relationships between HSCs and any subsets of CFU- 
S/pre-CFU-S  are unclear. 
Radioprotection is defined as the ability of transplanted 
hematopoietic cells to prevent lethally irradiated animals from 
hematopoietic death. Although the mechanisms underlying 
radioprotection are poorly understood, radioprotection often 
refers to a property of HSC activity. The radioprotective ca- 
pacity of HSCs has to satisfy two criteria: (a)  self-renewal 
capacity, which leads to long-term blood cell production; and 
(b) differentiation potential, which generates all blood cell 
types. 
In an attempt to purify HSCs using physical and biolog- 
ical separation methods, Jones et al. used counter-flow cen- 
trifugal elutriation to fractionate cells on the basis of size and 
density (11). In their experiment, one fraction of bone marrow 
cells (representing 25% of the bone marrow) was relatively 
depleted of CFU-S and granulocyte-macrophage CFU (CFU- 
GM), yet contained precursor cells for long-term engraftment. 
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of pre-CFU-S HSCs that  could be separated from CFU-S 
on day 8 and day 12 (11). 
This result was in apparent conflict with the findings of 
Spangrude et al. (12, 13), that HSCs could be identified and 
enriched according to cell surface phenotype. HSC activity 
was found in cells that expressed low but significant levels 
of Thy-l.1 (Thy-l.ll~  high levels of stem cell-associated an- 
tigen (Sea-l), and undetectable levels of blood cell lineage- 
specific differentiation markers (Lin).  This rare subset of bone 
marrow calls (~0.05%) was highly enriched by using anti- 
bodies in a combination of magnetic bead selection and FACS  ~ 
The  Thy-l.1 l~ Lin-  Sea-1 + calls  contained  a  1,000-2,000- 
fold enrichment of (a) late-forming CFU-S, (b) thymic CFU 
(CFU-T),  (c) progenitor  activity giving  rise to long-term 
hematolymphoid cultures,  and (d) radioprotective activity. 
Thus these cells were proposed as candidate HSCs (12,  14). 
Thy-l.1 l~ Lin-Sca-1 + cells are uniform in size as shown by 
Spangrude et al. (12). Recently Spangrude and Johnson showed 
that Thy-l.1 l~ Lin-  Sea-1 ~ calls can be further divided into 
rhodamine-123  low  and  high  (Rh123  l~ and  Rh123 hi)  cell 
types (15). The Kh1231~ Thy-11~  Lin-  Sca-1 + subset was also 
over 100-fold enriched for day 13 CFU-S activity (23 CFU- 
S/1,000 calls injected), but were about fourfold less potent 
than the Kh123 ~ subset (105 CFU-S/1,000 cells injected) in 
this assay. The Kh123  ~~ were most highly enriched for pre- 
CFU-S and long-term, multi-lineage reconstituting activity, 
as tested by secondary bone marrow transfer into lethally ir- 
radiated  mice (15). 
Nevertheless,  cells  that  are  not  of the  Thy-l.11~  Sea-1 + 
Lin-  phenotype might also contain a rare stem cell popula- 
tion, perhaps that described by  Jones et al. (11, 13). We there- 
fore sought in  this  study to test whether radioprotection, 
stir-renewal,  and/or long-term, multi-lineage blood cell recon- 
stituting  capacity could be found in Thy-l.l-,  Sea-l-,  or 
Lin + cells. We found that Thy-l.1 + but not Thy-l.l-,  Sea- 
l + but not Sea-l-  and Lin-  but not Lin + ceils contained 
all three HSC activities detected in the C57BL/Ka-Thy-l.1 
bone marrow. 
Materials  and Methods 
Mouse Strains.  The C57BL/6-Ly-5.1-Pep  3b (Thy-l.2,  Ly-5.1), 
C57BL/Ka-Thy-l.1 (Thy-l.1, Ly-5.1), C57BL/Ka-Ly-5.2 (Thy-l,2, 
Ly-5.2), and (C57BL/Ka-Thy-1.1 x  C57BL/Ka-Ly-5.2)F1 mouse 
strains used in the study were bred and maintained in the mouse 
facility at Stanford University (Stanford, CA). All mice were regu- 
larly maintained  on acidified water (pH 2.5). 
CellPrelmration.  Bone marrow cells were obtained by flushing 
tibias and femurs as described (12, 16). Cells were stained sequen- 
tially as follows: (a) cells were first incubated with lineage marker 
rat antibodies to B220 (RA3-6B2), CD4 (GK-1.5), CD8 (53.6.72), 
Gr-1 (RB6-8C5),  Mac-l(M1/70.15.11.5),  and erythrocytes (anti- 
body  TER-119); (b)  the  washed  cells were  then  exposed  to 
phycoerythrin-conjugated  goat antiserum to rat immunoglobulin 
(Biomeda, Foster City, CA); (c) the washed cells were then incubated 
in 20% normal rat serum to block free binding sites, followed by 
addition of biotinylated rat antibody to Sea-1 (antibody E13 161-7) 
and directly fluoresceinated mouse antibody to Tby-l.1 (antibody 
19XE5); and (d) the washed cells were then exposed to Texas red- 
conjugated avidin (Cappel Laboratories, Malvem, PA). The cells 
were incubated for 20 min on ice for each step, followed by a wash 
through a FCS cushion. After the final wash, cells  were rgsuspended 
in HBSS containing  1 ~g/ml propidium iodide. The hbded cells 
were analyzed and sorted with a dual laser FACS  |  (Becton Dick- 
inson Immunocytometry  Systems, Mountain View, CA), modified 
as described (17), and made available through the FACS  |  shared 
user group at Stanford University. Whole bone marrow (WBM) 
cells were separated on the basis of  background levels  of fluorescein 
(Thy-l.1-) from intermediate and high levels of fluorescein (Thy- 
1.1+), background low levels of Texas red (Sea-l-) from high levds 
of Texas red (Sca-l+), and background and low levels of phycoery- 
thrin  (Lin-) from high levels of phycoerythrin (Lin +). Dead cells 
were excluded from analysis by propidium iodide staining detected 
by the allophycocyanin channel. After sorting, each bone marrow 
fraction was reanalyzed by FACS  | 
Radioprotection and Long-Term Reconstitution Assays.  Recipient 
mice were lethally irradiated (9 Gy) by a 250-kV x-ray machine 
at 100 rad/min in two split doses (4.5 Gy each) with a 3-h interval. 
After irradiation,  mice were maintained on antibiotic water con- 
taining  106 U/liter  of polymyxin  B  sulfate and  1.1  g/liter  of 
neomycin sulfate. The next day, sorted bone marrow subsets or 
WBM cells were injected (200/~l/mouse)  intravenously into the 
retro-orbital plexus of anesthetized mice. Surviving animals were 
monitored  for 100 d (radioprotection  assay). 
For the long-term reconstitution assay, sorted donor bone marrow 
subsets were injected together with 10  s host congenic WBM cells 
to provide radioprotection. 
Peripheral  Blood Analysis.  Peripheral blood was obtained from 
the retro-orbital  sinus. Immunofluorescence staining and FACS  | 
analysis were performed as described previously (12, 16). Two-color 
staining was carried out using monoclonal antibodies specific for 
lineage marker for B cells (anti-B220), mydoid cells (anti-Gr-1 and 
anti-Mac-I), or T cells (anti-Thy-l.1) alone with antibodies to con- 
genic markers specific for donor hematopoietic cells (anti-Ly-5.2, 
antibody A20.1). 
Results 
Experimental  Design.  We wanted to test whether Thy- 
1.1  l~ Lin-  Sea-1 +  cells  were  the  only  cells  in  the  bone 
marrow that have pluripotent HSC activity. To avoid excluding 
any bone marrow cell populations from the analysis, we decided 
to determine how HSC activity was divided among  Thy- 
1.1 + versus Thy-l.1-  pools, Sea-1  + versus Sea-l- pools, and 
Lin-  versus Lin § pools. To measure HSC activity we chose 
two experimental  assays: (a) radioprotection, followed by long- 
term, multi-lineage reconstitution of T cells, B cells, and my- 
elomonocytic cells in surviving mice; and (b) long-term, multi- 
lineage reconstitution by donor cells when radioprotection 
is provided by congenic host WBM cells. 
If HSCs are rare and express these antigens uniformly, HSCs 
will be enriched in one fraction and correspondingly depleted 
in the other. Bone marrow cells from C57BL (Thy-l.1, Ly- 
5.2) congenic mice were separated into two (-  or  +) frac- 
tions on the basis of expression of Thy-l.1, Sea-l, or Lin (Fig. 
1). Frequency analysis  of both  -  and  +  populations show 
Thy-l.1 + cells (representing  4%  of WBM cells)  and Thy- 
1.1 -  ceUs (96% of WBM cells), Sca-1 § cells (6% of WBM 
cells)  and Sea-l-  cells (94%  of WBM cells), or Lin-  cells 
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analysis of  bone marrow cells from C57BL/Ka-Tby-l.1  ￿  C57BL/Ka-Ly- 
5.2)F1 mice. Density plots of Thy-l.1,  Sea-l, and lineage marker stainings 
are shown. The percentages in the panel indicate negative or positive cell 
fractions  defined by the gates shown (dotted lines). The lineage  markers 
include a panel of rat antibodies against B cells (anti-B220),  macrophages 
(anti-Mac-I),  granulocytes (anti-Gr-1), erythrocytes  (antibody  TER-119), 
and T cells (anti-CD4 and anti-CD8).  (b) Reanalysis of sorted bone marrow 
cells. Tby-l.1 +, Sea-1  +, or Lin- fractions (not shaded) are separated from 
Thy-l.l-,  Sca-l-, or Lin + fractions  (shaded), respectively. 
(11% of WBM cells) and Lin § cells (89% WBM cells) (Fig. 
1).  Under these sorting conditions, we obtained Thy-l.1- 
cells (98% pure upon reanalysis), Thy-l.1 + cells (64% pure), 
Sca-1-  cells  (98%  pure),  Sca-1  +  (80%  pure),  Lin-  (95% 
pure),  and  Lin +  cells  (96%  pure)  (Fig.  1).  For  technical 
reasons we could not sort highly purified Thy-l.1 + cells or 
Sca-1 +  cells.  Because  we  assumed  that  no  HSC  activity 
would be found in Thy-l.1-  or Sca-1-  cells,  the contami- 
nation of these cell populations should not contribute to radio- 
protection. 
The Ly-5.2 donor sorted cells were injected into C57BL/6- 
Ly-5.1 hosts so that in reconstituted animals all donor cells 
Table  1.  Number of Cells Injected for Radioprotection Assay 
NO.  of cells injected 
Percent  cells  Low cell  High cell 
Cells injected  of bone  marrow  number  number 
WBM  100  4  x  104  2  x  l0  s 
Thy-l.1-  96  4  x  104  2  x  103 
Thy-l.1 §  4  2  x  103  6-8  x  103 
Sca-1-  94-95  4  x  104  2  x  103 
Sca-1 +  5-6  3-4  x  103  1  x  104 
Lin +  82-89  3  x  104  2  x  10  s 
Lin-  11-18  4-5  x  103  2  x  104 
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Figure 2.  Protection from lethal irradiation by various fractions of bone 
marrow cells. Groups  of 10 mice per experiment  from three separate ex- 
periments  were lethally irradiated (8 or 9 Gy) and injected with different 
bone marrow fractions  as shown in Fig.  1 b. The data were combined 
from three independent experiments; each experiment had similar survival 
kinetics. Mice were reconstituted  with two different numbers  (PDs0 and 
PD9s, low and high, respectively) of WBM cells (a and b), Thy-l.1- vs. 
Thy-l.l*  cells (c and d), Sca-1-  vs. Sea-I § cells (e and)~,  and Lin-  vs. 
Lin +  cells  (g  and  h),  as  described  in  Table  1.  The  numbers  of mice 
presented  in the figure are as follows:  no cells, n  =  30;  WBM and  all 
bone marrow fractions, n  =  20. The groups of mice injected with Thy- 
1.1 + , Sea-1  + , and Lin- fractions are shown with solid lines. The groups 
of mice injected  with Thy-l.l-, Sea-l-, and Lin + fractions  are shown 
with broken lines. The shaded line in each panel represents  a group of 
mice with no cells injected,  as an irradiation  control. (Although the in- 
tended dose of irradiation  was 9 Gy, in one experiment  mice were irradi- 
ated at 8 Gy due to an x-ray machine calibration error.) In the Lin- group 
(e), a single cage of animals all died on day 7, whereas the control group 
(no cells injected) did not start dying until later. We have shown the results 
both  including (labeled Lin-,  n  =  20)  and  excluding  (labeled Lin-*, 
n  =  15) data  from these animals. 
and their progeny could be distinguished by a monoclonal 
antibody specific for Ly-5.2.  Furthermore, Thy-l.1 and Thy- 
1.2 allelic markers allowed us to identify and follow donor- 
derived T  cells in reconstituted animals. 
Which Bone  Marrow  Subsets  Mediate  Radiot~rotection  of  Lethally 
Irradiated Mice?  HSC activity was tested by injecting the 
sorted bone marrow subsets  intravenously into lethally ir- 
radiated mice. These separated  -  versus  +  pools were ex- 
amined for their ability to protect lethally irradiated mice 
from  hematopoietic  death  for  at  least  100  d  (i.e.,  radio- 
protection). 
To provide the most sensitive assay for enrichment or deple- 
tion of radioprotective activity, we transferred these cells in 
177  Uchida and  Weissman numbers corresponding  to  their representation  in  WBM  a 
predicted  to  be  50%  radioprotective  (PDs0  =  4  x  104  lO0-  / 
WBM cells) and 95-100% radioprotective (PDgs =  2  x  10  s  8o_| 
WBM cells).  These were designated, respectively,  the low 
dose group and the high dose group; the actual numbers of 
cells injected is given in Table 1. Fig. 2 shows the percentage  4 
of surviving animals given low versus high doses of either  2o 
WBM  or of the FACS|  populations. 
When the lethally irradiated mice received no cells,  the  c 
majority of the mice died 10-18  d (90%) after irradiation.  100] 
In this study we observed survival of 1 in 30 animals injected  80~ 
with no cells. No animals survived that were injected with  --~ 
t 
"~  80 
the PDs0 equivalent dose of Thy-l.l-, Sea-l-, or Lin + cells,  o 
It should be noted that mice receiving Thy-l.1-  or Sea-l-  ~  40 
cells, indicated by arrows in Fig.  2, c and e, survived ~6 d  o~  2o 
longer on average than mice receiving no cells. In contrast,  "o  0 
radioprotective activity was detected in the PDs0 equivalent  "~  ￿9  e 
dose of Thy-l.l+, Sea-l+, Lin- cells: 45% by the Thy-l.1 +  ~  100. 
subset,  65%  by the Sea-1 §  subset,  and 47%  by the Lin-  O_ 
subset.  80- 
Mice injected with the PDgs equivalent of Thy-l.1-, Sea-  48- 
1-,  or  Lin +  cells  also  survived poorly:  20,  5,  and 20% 
2O- 
animals, respectively, survived 100 d after transplantation. As 
indicated by arrows in Fig.  2, d, f, and h, the majority of  c 
mice receiving Thy-l.l-, Sea-l-, or Lin § cells survived ",~7,  o 
6, and 12 d longer on average than mice receiving no cells.  10~ 
Radioprotection was provided by the PDgs equivalent dose  i188 
of Thy-l.1 + (75%),  Sea-1  + (95%),  or Lin-  (80%)  cells. 
It is evident from these experiments that Thy-l.l-,  Sea- 
l-, or Lin + cell populations, which represent ,'o82-96% of 
WBM cells, were significantly depleted for their ability to  0. 
radioprotect lethally irradiated mice. The survival kinetics 
provided by Thy-l.1 *, Sea-1 +, and Lin- cell populations at 
both cell doses were similar to those with low or high doses 
of WBM cells. Thus the radioprotective activity of WBM 
cells is a property of Thy-l.l+,  Sea-l+,  and Lin-  cells. 
The surviving animals described above must have been ra- 
dioprotected either by progeny of donor HSCs or by a tran- 
sient population of circulating donor-derived blood cells fol- 
lowed by recovery of endogenous HSC activity. If long-term 
radioprotection was provided by progeny from donor HSCs, 
we should observe long-term, multi-lineage reconstitution 
by donor cells. We tested the levels of donor-derived, Ly-5- 
marked peripheral blood cells in each lineage at 100 or 180 d 
after irradiation and cell injection (Fig. 3). We analyzed the 
mice injected with the PDgs equivalent cell dose. From past 
studies detection of sustained myelopoiesis is a good indi- 
cator of active hematopoiesis from HSCs and progenitor cells 
(18; Uchida, N., and I. L. Weissman, unpublished observa- 
tions), because mature granulocytes are short-lived (on av- 
erage <24  h)  once they enter  the blood  circulation  (18; 
Uchida, N., and I.L. Weissman, unpublished observations). 
It is clear that consistent long-term, multi-lineage reconsti- 
tution occurs only with WBM, Sea-1  + , Lin-, or Thy-l.1 + 
cells (Fig.  3, b, d, f, and h). It should be noted that in the 
experiment shown in Fig. 3 h, we were only able to inject 
6  x  103  Thy-l.1 +  cells  into  each recipient,  a  dose  that 
Figure 3. 
No ceils injected  b  2 x 10 5  WBM 
Survival: 1 in 10  Survivah 9 in 10 
4O 
2O 
0  -- 
2x10 5  Sca-1-  d  lx10 4  Sca-1 + 
Survival: 1 in 10  Survival: 10 in 10 
80 
60 
40 
~  20 
~  o 
2x10 5  Lin  +  f  2x10 4  Lin- 
Survival: 3 in 10  Survival: 7 in 10 
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Survival:  2 in 10  Survival: 6 in 10 
80 
60 
40 
20 
B  M&G  T  o  B  M&G  T 
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The levels of donor-derived cells in each lineage in irradiated 
mice reconstituted  with the cell subsets shown in Fig. 2. The levels of 
donor-derived, Ly-5-marked cells originated from Thy-l.1, Sea-l, or Lin, 
defined subset in each lineage was determined.  Peripheral blood cells of 
mice that received the PDgs equivalent from each cell fraction were ana- 
lyzed in mice surviving 100 d (a-J) or 180 d (g and h) after injection. The 
fraction of donor-derived cells was calculated as a percentage of total cells 
in each separate hematolymphoid cell type. Each of the curves represents 
the number of B (B220 positive), myeloid (Mac-1  +/GK-1 +), and T (Thy- 
1big  h) lineage cells from a single animal. 
represents only two-thirds of the expected PD9s equivalent 
cell dose. 
We also tested the surviving animals that received no cells, 
or the PDgs equivalent dose of Thy-l.l-,  Sea-l-, or Lin + 
cells. No multi-lineage reconstitution was detected except from 
one mouse injected with 2  x  10  s Thy-l.1-  cells (Fig. 3, a, 
c, e, and g). We believe these surviving animals were almost 
certainly radioprotected due to repopulation by endogenous 
stem cells that survived the irradiation. As pointed out above, 
mice receiving Thy-l.l-,  Sea-l-, or Lin + cells survive, on 
average, a few days longer than mice receiving no cells, im- 
plying that these cells might contain short-term engraftment 
activity. In that way, a few of these mice may have survived 
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Figure 4.  The levels of donor-derived T cells in 
Thy-1 congenic chimeras after the irradiation and 
injection of Thy-l.1- or Thy-l.1 + bone marrow 
cells. The levels of donor-derived, Thy-l-marked 
T cells at 80 d after the irradiation and injection 
were determined by analysis  of  irradiated mice that 
received the PDs0 or PDgs equivalent of Thy-l.1- 
or Thy-l.1 + bone marrow cells. Donor-derived T 
cells levels were calculated by taking the ratio of 
Thy-l.lhi~  h to  Tby-l.1 hiSh  +  Thy-l.2hls  h cells. 
*Mice surviving 80 d. 
Table  2.  Long-Term Multi-Lineage  Reconstitution of Irradiated 
LT-5 Congenic Mice with  WBM,  Sca-I-,  Lin +, or Thy-l.1-  Cells 
Plus 10  s Host-Type  WBM 
Multi + 
(B+  M/G  + T) 
Week 
Donor cell  No.  of cells 
type  injected  n  4  8-10  13-14 
WBM  4  x  10  4  4  1  4  3 
Sea-l-  4  x  104  4  0  0  0 
Lin*  4  x  10  4  5  0  0  0 
Thy-l.1-  4  x  104  5  1  1  0 
Thy-l.1-  2  x  10  s  5  0  0  0 
Peripheral blood of the reconstituted mice was analyzed at three time 
points  as  indicated.  The  mice  reconstituted  with  all  three  lineages 
(Multi +) were scored ff they had detectable levels (>1%) of donor- 
derived B cell lineage (B), myelomonocytic cell lineage (M/G), and T 
cell lineage (T) at each time point (B +  M/G  + T). 
for sufficient time to allow repopulation by endogenous he- 
matopoiesis. 
1 of the 10 mice injected with 2  x  10  s Thy-l.1-  cells in 
one experiment showed donor-derived, multi-lineage recon- 
stitution (Fig. 3 g). This was the only mouse that had multi- 
lineage repopulation  from  the  groups  receiving Thy-l.l-, 
Sca-l-, or Lin + cells in this entire study (only 7 of 120 mice 
survived).  While  it  is possible that  the  Thy-l.1-  fraction 
may contain  extremely rare stem cells,  it is more likely to 
be due to the cross-contamination  because of the  technical 
difficulty in separating Thy-l.1 l~ cells from Thy-l.1-  cells. 
In this experiment  there was some overlap in the distribu- 
tion  of  cells  expressing  background  levels  of  Thy-l.1- 
fluorescein intensity and one with Thy-l.1 l~ expression (Fig. 
1  b).  Because  we  used  (C57BL/Ka-Ly-5.1-Thy-l.1  x 
C57BL/Ka-Ly-5.2-Thy-l.2)Ft  mice  for  hematopoietic  cell 
sources,  the  level of Thy-l.1  on  Ft  cells  was decreased by 
hals 
To obtain the best sorting conditions for the Thy-l.1 an- 
tigen, another experiment was performed using C57BL/Ka- 
Thy-l.1 donors and C57BL/Ka (Thy-l.2) Thy-1 conic  hosts 
(Fig. 4). T  lineage reconstitution  was detected when either 
Table  3.  Long-Term Reconstitution of Irradiated Ly-5 Congenic Mice with  WBM,  Sca-l-,  Lin +, or Thy-l.1 + Cells Plus 
I0  s Host-Type  W73M 
B  M/G  T 
Week  Week  Week 
Donor cell  No.  of cells 
type  injected  n  4  8-10  13-14  4  8-10  13-14  4  8-10  13-14 
WBM  4  x  104  4  4  4  4  4  4  3  1  4  4 
Sca-1-  4  x  104  4  2  0  0  0  0  0  0  1  1 
Lin +  4  x  104  5  4  3  2  1  1  1  0  3  2 
Thy-l.1-  4  x  104  5  5  4  4  1  1  0  2  1  1 
Thy-l.1-  2  x  10  s  5  5  5  5  0  1  2  2  1  0 
Peripheral blood of the reconstituted  mice was analyzed at three time points as indicated. Mice were scored positive ff they had detectable levels 
(>1%) of donor-derived B cell lineage (B), myelomonoeytic cell lineage (M/G), or T cell lineage (T) at each time point. 
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Host-Type WBM 
Percent donor cells 
No.  of cells  Lineage 
Fraction  injected  analyzed  Week 4  Week 8  Week 13-14 
WBM (n  =  4) 
Sca-1-  (n  =  4) 
Lin  + (n  =  5) 
4  x  104  B  8.8  27  60 
M  & G  2.8  81  96 
T  <1  4.1  52 
4  x  104  B  12  15  36 
M  & G  5.5  38  47 
T  <1  7.0  16 
4  x  104  B  9.4  9.6  8.9 
M  & G  7.8  13  <1 
T  <1  1.5  8.6 
4  x  104  B  18  45  63 
M  & G  23  27  24 
T  1,5  39  34 
4  x  104  B  1.7  <1  <1 
M  & G  <1  <1  <1 
T  <1  3.0  4.0 
4  x  104  B  <1  <1  <1 
M  & G  <1  <1  <1 
T  <1  <1  <1 
4  x  10  4  B  <I  <I  <1 
M  & G  <1  <1  <1 
T  <1  <1  <1 
4  x  104  B  1.0  <K1  <1 
M  & G  <1  <1  <1 
T  <1  <1  <1 
4  x  104  B  11  3.1  1.3 
M  & G  <1  <1  <1 
T  <1  1.4  <1 
4  x  104  B  4.4  5.7  4.0 
M  & G  36  <1  <1 
T  <1  6.4  9.1 
4  x  104  B  3.0  <1  <1 
M  & G  <1  <1  <1 
T  <1  <1  <1 
4  x  104  B  1.4  1.4  <1 
M  & G  <1  10  6.0 
T  <1  <I  <1 
continued 
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Fraction 
No.  of ceHs  Lineage 
injected  analyzed 
Percent donor cells 
Week 4  Week 8  Week 13-14 
Thy-l.1-  (n  =~  5) 
Thy-l.1-  (n  =  5) 
4  x  104  B  <1  <1  <1 
M&  G  <1  <1  <1 
T  <1  2.3  1.1 
4  x  104  B  3,3  <1  <1 
M  &  G  <1  <1  <1 
T  <1  <1  <1 
4  x  104  B  17  28  26 
M  &  G  9.6  1.2  <1 
T  1.1  6.8  1.4 
4  x  104  B  6.1  1.2  1.5 
M  &  G  <1  <1  <1 
T  <1  <1  <1 
4  x  104  B  8.2  2.8  2.0 
M  &  G  <1  <1  <1 
T  <1  <1  <1 
4  x  104  B  16  4.5  3.6 
M  &  G  <1  <1  <1 
T  1.2  <1  <1 
2  x  105  B  34  13  13 
M  &  G  <1  2.2  3.4 
T  <1  <1  <1 
2  x  10  s  B  14  5.5  5.6 
M  &  G  <1  <1  <1 
T  1.6  <1  <1 
2  x  10  s  B  27  12  13 
M  &  G  <1  <1  2.0 
T  <1  <1  <1 
2  x  10  s  B  15  2.8  3.2 
M  &  G  <1  <1  <1 
T  <1  <1  <1 
2  x  l0  s  B  18  16  15 
M  &  G  <1  <1  <1 
T  2.5  3.3  <1 
WBM or the Thy-l.1 + subset of WBM was used at either 
the PDs0 or PD9s equivalent doses. Donor T  cells were de- 
tected in the PDs0 equivalent  dose of WBM  (53  _+  19%) 
and Thy-l.1 + (52  _+  20%).  Averages of 73  +  7 and 69  + 
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15 %  of donor T cells, respectively, were detected in the blood 
of mice that received the PD9s equivalent dose of WBM and 
Thy-l.1 + cells,  whereas only 4%  of donor T  cells were de- 
tected  from the  single  surviving animal  injected with  the PDgs equivalent dose of Thy-1- cells. Thus we could detect 
radioprotective and T lineage repopulating activities in WBM 
and Thy-l.1 + cells, but not in Thy-l.1-  cells. 
Which Bone Marrow Subsets Mediate Long-Terra Multi-Lineage 
Reconstitution in Mice Radioprotected by Host IYBM Cells?  The 
experiments described above show that Thy-l.l-,  Sca-l-, 
and Lin + cells do not radioprotect lethally irradiated mice. 
This assay does not exclude the possibility that cells contained 
in the Thy-l.l-,  Sca-l-,  or Lin +  subsets do indeed have 
long-term engraftment activity, but this could not be de- 
tected if they failed to radioprotect in the short term. Jones 
et al. reported that they could isolate a bone marrow subset 
that contained long-term repopulating but not radioprotec- 
tire activity (11). We wanted to test whether similar activity 
was present among Thy-l.1-, Sca-l-, or Lin + cells. To pro- 
vide these cells the opportunity to demonstrate long-term 
engraftment,  1  x  10  s host bone marrow cells were coin- 
jected with each donor bone marrow fraction tested. As the 
long-term engraftment potential of Thy-l.l+,  Sca-l+,  and 
Lin- cells had already been tested, we limited our examina- 
tion of possible long-term repopulating ability of Thy-l.l-, 
Sca-l-, and Lin + cells, and compared it with that of WBM 
cells. Tables 2, 3, and 4 show the results of long-term recon- 
stitution assays of irradiated Ly-5 congenic hosts given sorted, 
donor cell populations plus 1  x  10  s host-type WBM cells 
for radioprotection. Under these conditions it is clear that 
Thy-l-,  Sca-l-,  and  Lin +  cells  could  not  contribute  to 
long-term, multi-lineage reconstitution (Table 2). An equiva- 
lent dose of WBM cells could contribute to significant levels 
of long-term, multi-lineage reconstitution (Table 4). In three 
of four mice in this WBM group, 24-96% of peripheral my- 
doid cells were donor derived 14 wk after transplantation. 
Some short-term engraftment was observed with Thy-l.l-, 
Sca-l-,  or Lin + cells (Tables  3 and 4). Thy-l.1-  cells con- 
tained reproducible and significant B cell progenitor activity, 
while no long-term B cell progenitor activity was detected 
in Sca-1-  cells  (Tables  3  and 4).  Thus,  these progenitors 
must be Sca-1 + , but may be Lin + or Lin- cells. By the two 
approaches described above we found that radioprotective ac- 
tivity tightly  correhted with long-term,  multi-lineage repopu- 
lation activities. 
Discussion 
Only Thy-I.1 t~ Lin-Sca-I + Bone Marrow  Cells Are HSCs. 
In these experiments we searched for HSC activity in all frac- 
tions of bone marrow by radioprotection and long-term recon- 
stitution assays. The experimental design allowed us to de- 
tect  two  possible  HSC  activities:  (a)  radioprotective  and 
long-term,  multi-lineage repopulating,  and (b)  not radio- 
protective,  but  long-term  repopulating.  Tby-l.1-  cells 
(representing  96%  of WBM),  Sca-1-  cells  (94-95%  of 
WBM),  and Lin + cells (82-89%  of WBM)  neither radio- 
protected nor contributed to long-term, multi-lineage recon- 
stitution. Long-term, multi-lineage reconstitution was a prop- 
erty ofThy-l.1 + (4% ofWBM), Sca-1 § (5-6% of WBM), 
and Lin-  (11-19%  of WBM) cells. Thus, Thy-l.l-, Sca-l-, 
and Lin + cells,  which together represent 99.95%  of bone 
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marrow  cells,  do not possess  stem cell activity.  Thy-l.1 l~ 
Lin-Sca-1 + cells, but no other cells,  appear to be the only 
pluripotent hematopoietic stem cells in adult C57BL/Ka-Thy- 
1.1 bone marrow as measured by these assays (radioprotec- 
tion and long-term,  multi-lineage reconstitution). 
It is most likely that the same population also has self- 
renewal activity. Elsewhere we have shown that hosts demon- 
strating sustained, donor-derived myelopoiesis (>t6 mo) con- 
tain bone marrow cells that can transfer radioprotection and 
long-term, multi-lineage hematopoiesis to secondary hosts 
(15,  18).  In these experiments, clonogenic Thy-l.1 l~ Lin- 
Sca-1 + Ly-5 marked single cells (or donogenic units found 
at limit dilution) were transferred into Ly-5 congenic hosts 
along with  either  1  x  10  s WBM  or  100 Thy-l.11~ Lin- 
Sca-1 + host cells. Two outcomes were evident when donor- 
derived cells could be detected in the blood: multi-lineage 
differentiation that fails to sustain myelopoiesis, and multi- 
lineage outcomes that sustain myelopoiesis (18; Uchida, N., 
and I. L. Weissman, unpublished observation). Only those 
chimeras with sustained donor-derived myelopoiesis contained 
donor-derived cells that could yield long-term, multi-lineage 
outcomes after secondary transplantation.  Only WBM  or 
Thy-l.11~ Lin- Sca-1 + cells contain such activity (18; Uchida, 
N., and I. L. Weissman, unpublished observations). Because 
virtually all mice given PDs0 or PDgs doses of Thy-l.1 + , 
Lin-,  or Sca-1 + cells exhibited sustained myelopoiesis, we 
infer that self-renewal has also occurred in these cases. Be- 
cause no mice given Thy-l.l-,  Lin + , or Sca-1-  cells (along 
with host WBM cells)  demonstrated donor-derived, long- 
term, multi-lineage reconstitution, these populations do not 
contain pre-CFU-S  or self-renewing HSCs. 
We found no evidence for the existence of cells that aug- 
ment or inhibit HSC activity, as mixing WBM cells with 
the sorted populations appeared to neither inhibit the Lin- 
fraction (12) nor help the Lin + fraction. It is interesting to 
note that Thy-l-, Sca-l-, and Lin + cells provided some de- 
gree of short-term or lineage-restricted engraftment. For ex- 
ample, the Thy-l.1-  fraction gave rise to a large number of 
B cells in one of four mice injected with 2  x  104 cells, and 
in four of five mice injected with 2  x  10  s cells over the full 
length of assay. This is consistent with the presence of these 
progenitors in a Thy-1-  fraction reported previously (19). 
Jones et al. used counterflow centrifugal elutriation to sep- 
arate bone marrow cells into four fractions on the basis of 
size and density (11). Progenitor activities of these cells were 
assayed by day 8 and day 12 CFU-S and by CFU-GM. They 
used male-spedfic DNA probes to trace donor-origin engraft- 
ment at days 11 and 60. One fraction of cells that elutriate 
at 25 ml/min (representing 25% of input cells) was enriched 
for morphologic lymphocytes and depleted of blast cells. This 
fraction was significantly depleted for progenitor cells that 
could produce CFU-GM and CFU-S; 1  x  10  s of these cells 
could not radioprotect lethally irradiated animals, but did con- 
tain a long-term progenitor activity (see below).  Another 
fraction,  representing  '~25%  of bone  marrow  cells,  was 
highly enriched for blast cell types. This fraction contained 
CFU-GM and CFU-S activities, and could radioprotect 15 
of 28 animals given 2  x  104 cells for at least 60 d. Donor- derived cells in bone marrow of the reconstituted animals, 
detected by dot blots probed for male-specific DNA,  were 
decreased from 98%  of male donor type at day 14 to 11% 
at day 60. 
Interestingly, 2  x  104 male donor 25 ml/min cells con- 
tained multi-lineage reconstitution activity assayed at day 60 
when the irradiated mice were radioprotected by 2  x  104 
female "blast" fraction cells.  While these hosts had no de- 
tectable male donor cells in bone marrow at day 14,  male 
donor cells were detected in bone marrow at abundant levels 
('~50%  of normal) at day 60. Jones et al.  concluded that 
two independent classes of bone marrow cells mediate two 
different phases of hematopoietic recovery in lethally irradi- 
ated animals. The "blastic" fraction would contain committed 
progenitors that provided radioprotection via rapid, but short- 
term engraftment, while the 25 ml/min fraction contained 
pre-CFU-S or "true" HSC that could not contribute to radio- 
protection by early stage myeloerythroid development, but 
contained cells that could produce delayed, multi-lineage recon- 
stitution  (11). 
Can these results be reconciled with the data presented here 
and elsewhere describing activities of Thy-l.1 I~ Lin- Sca-1 + 
cells? Thy-l.lI~  + cells are similar in size to the 25 
ml/min fraction,  as shown by Spangrude et al.  (12).  Also, 
~97%  of this cell type are in the Go-G1 phase. Combining 
these findings, Thy-l.11~ Lin-Sca-1 + cells should not be in- 
cluded in a fraction enriched for blast cells. Yet they are highly 
enriched for day 12 CFU-S,  in contrast to the 25 ml/min 
fraction of  Jones et al. (11), and are responsible for both long- 
and short-term reconstitution.  It has been shown that sev- 
eral different cell types can contribute to CFU-S (8). Purified 
Thy-l.ll~  + cells have low day 8  CFU-S  activity 
and high day 12-13 CFU-S activity (1:10 ratio), while three 
other FACS|  populations give rise to CFU-S with 
varying ratios of day 8/day 12 activity (8). It is unclear which 
populations were deleted from the 25 ml/min fraction de- 
scribed by Jones et al. (11). The enrichment or depletion of 
CFU-S and long-term progenitor activities in fourfold en- 
riched populations is, of course, much different than the highly- 
enriched activities  described in a  subset representing only 
0.05%  of WBM. 
Nevertheless, the findings of Jones et al.  (11) raise ques- 
tions  concerning  the  "homogeneity"  of  the  Thy-l.11~ 
Lin-Sca-1 + cells.  In fact, they appear to be heterogeneous. 
Spangrude and Johnson showed that Thy-l.1 l~ Lin-  Sca-1 + 
cells can be further divided into rhodamine-123 low and high 
(Rh123 I~  Rh123 hi) cell  types  (15).  While  WBM  contain 
"~0.15 day 13 CFU-S per 1,000 cells injected, R.h123  hl Thy- 
1.1  l~ Lin-Sca-1 + ceils were highly enriched for day 13 CFU-S 
activity (105 CFU-S per 1,000 cells injected), but were not 
correspondingly enriched for pre-CFU-S or long-term multi- 
lineage reconstituting activity in lethally irradiated hosts (15; 
Uchida, N., and I.L. Weissman, unpublished observations). 
The Rh123  l~ Thy-11~  + subset was also >100-fold 
enriched for day 13 CFU-S activity (23 CFU-S per 1,000 cells 
injected),  but  were  about  fourfold  less  potent  than  the 
R.h123 hi subset in this assay. Most striking, the Rh1231~ were 
most highly enriched for pre-CFU-S and long-term, multi- 
lineage reconstituting activity, as tested by secondary bone 
marrow or spleen transfer into lethally irradiated mice (15). 
Thus,  Thy-l.ll~  +  cells  include both  short-  and 
long-term reconstituting activities. It is yet to be determined 
whether the Rh-123 defined subsets in fact correspond to 
the counterflow elutriation subsets. 
There are several variables that could account for the ap- 
parent differences between Jones et al. (11) and our studies. 
First, we have used C57BL/Ka-Thy-1.1 mice, mainly because 
our best anti-Thy-1 staining antibody detects the Thy-l.1 al- 
lele, and also because they are closely related to Thy-1 and 
Ly-5 congenic mouse lines. Jones et al. used B6D2F1 mice 
in their studies (11). Thus strain differences in HSC proper- 
ties could exist. In fact, Spangrude has recently found that 
pre-CFU-S  activity  resides  in  both  Thy-l.2 l~ and  Thy- 
1.2-Sca-1 +Lin-  cells in C57BL/Ka (Thy-l.2) bone marrow, 
whereas it is present only in Thy-l.1 l~ cells in C57BL/Ka- 
Thy-l.1 bone marrow (Spangrude, G., manuscript in prepa- 
ration). 
Recently Chandhary and Roninson showed that Rh-123 
staining of human myeloerythroid progenitors was inversely 
correlated with the expression of the MDRI (multi-drug re- 
sistance) gene product P-glycoprotein (20). Low levels of Rh- 
123 staining of hematopoietic cells resulted from its export 
by the P-glycoprotein. It will be interesting to find out whether 
the  heterogeneity  of Rh-123  staining  of Thy-l.1 l~ Lin- 
Sca-1 + subsets can be explained by the differential P-glyco- 
protein expression. 
It is important to note that very low numbers (50-100 
cells)  of Thy-1.11~  + cells are capable of radiopro- 
tecting and reconstituting lethally irradiated animals.  It is 
this combination of activities that will be required for human 
bone marrow transplantation to provide patients with long- 
term engraftment while preventing short-term hematopoi- 
etic failure. 
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